Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04893226 · ClinicalTrials.gov registry record · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
A NA study of Metabolic Syndrome and Postmenopausal Symptoms, sponsored by Julie Pendergast.
- Recruiting
- Registry status
- NA
- Development phase
- 164
- Enrollment target
- 1
- Study location
NCT04893226: Recruiting NA study of Metabolic Syndrome and Postmenopausal Symptoms, sponsored by Julie Pendergast.
NCT04893226 is a NA study of Metabolic Syndrome and Postmenopausal Symptoms that is actively recruiting participants, run by Julie Pendergast. The registered enrollment target is 164 participants, below the 1,203-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04893226, a NA study of Metabolic Syndrome and Postmenopausal Symptoms, is actively recruiting participants, sponsored by Julie Pendergast.
- RECRUITING
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, parallel two-arm clinical trial design to study the efficacy of time-restricted feeding on metabolic risk in postmenopausal women, who may be particularly vulnerable to disruption of circadian eating rhythms and the associated metabolic dysfunction. It is hypothesized that time-restricted feeding will improve insulin sensitivity, glucose tolerance, body weight, and other metabolic parameters in metabolically-unhealthy postmenopausal women.
Primary Outcome
Matsuda index will be assessed by the oral glucose tolerance test (OGTT).
Conditions Studied
Interventions
- BEHAVIORAL Time-Restricted Feeding (TRF)
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2021-10-19 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
What NCT04893226 shows while recruiting
NCT04893226 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 1,203-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Metabolic Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Time-Restricted Feeding (TRF) is the first listed.
NCT04893226 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT04893226 about?
NCT04893226 is a clinical study titled "Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women". This is a randomized, parallel two-arm clinical trial design to study the efficacy of time-restricted feeding on metabolic risk in postmenopausal women, who may be particularly vulnerable to disruption of circadian eating rhythms and the associated metabolic dysfunction. It is hypothesized that time...
What is the current status of trial NCT04893226?
This trial is currently recruiting. It is a NA study. The enrollment target is 164 participants. The study started on 2021-10-19. Estimated completion is 2027-01-31.
What conditions does trial NCT04893226 study?
This clinical trial studies the following conditions: Metabolic Syndrome, Postmenopausal Symptoms.
What interventions are being tested in trial NCT04893226?
The interventions under investigation include: Time-Restricted Feeding (TRF) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04893226?
This trial is sponsored by Julie Pendergast, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04893226 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04893226's enrollment target sits among peer trials
164 23rd of 102 higher than 80 of 102 other Metabolic Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolic Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Animal and Plant Proteins and Glucose Metabolism
RECRUITING · NA
-
VR Stimulation of Exercise Response in Sedentary Humans
RECRUITING · NA
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
- NCT05612594 · 164 participants · Phase 4
Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI